LY 215490

Known as: LY-215490 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2006
01219942006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
This study was conducted to examine reflex mechanisms that mediate urinary bladder and external urethral sphincter (EUS… (More)
Is this relevant?
Review
2001
Review
2001
  • Ian Gilron
  • Current opinion in investigational drugs
  • 2001
Lilly is developing the racemic compound LY-215490, a selective and competitive AMPA antagonist, as a potential treatment for… (More)
Is this relevant?
1996
1996
Chemical irritation of the lower urinary tract (LUT) of the rat increases the expression of the immediate early gene c-fos within… (More)
Is this relevant?
1994
1994
LY 215490 (3RS,4aRS,6RS,8aRS)-6-[2-(1(2)H-tetrazole-5- yl)ethyl]decahydroisoquinoline-3-carboxylic acid), a novel, selective… (More)
Is this relevant?
Review
1994
Review
1994
  • Rammy Gill
  • Cerebrovascular and brain metabolism reviews
  • 1994
The development of selective, systemically active alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate… (More)
Is this relevant?